Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Manual for Vegetarian Protein Powder - 2NASA launches science balloon in Antarctica | Space photo of the day for Dec. 22, 2025
- 3UK forecast to face weaker growth and higher inflation from Iran war
- 4The Leonid meteor shower is peaking early this week. Here’s what to know
- 5Israel has clear objectives south of Litani River, but will face difficult choices further north
- Oldest evidence of human fire-making discovered at site in England
- Where should we send a real 'Hail Mary' spacecraft? A new study has the answers
- Supercharge Your Remote Work Arrangement with These Game-Changing Instruments
- Exploiting Unsold Rams: May Be Less expensive Than You Suspect
- Figure out how to Put resources into Lab Precious stones: A Novice's Aide
- Change Your Home into an Exercise center with These Famous Wellness Gadgets
- 'Dancing With the Stars' Season 34 finale: Who might win the mirror ball trophy? Where do the remaining contestants rank?
- Taylor Swift's 'The End of an Era' docuseries: Everything you need to know, plus how to watch for less
- Figure out How to Pick the Right Dental specialist for Your Dental Inserts
